Siwecka, N.; Saramowicz, K.; Galita, G.; Rozpędek-Kamińska, W.; Majsterek, I.
Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy. Pharmaceutics 2023, 15, 2051.
https://doi.org/10.3390/pharmaceutics15082051
AMA Style
Siwecka N, Saramowicz K, Galita G, Rozpędek-Kamińska W, Majsterek I.
Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy. Pharmaceutics. 2023; 15(8):2051.
https://doi.org/10.3390/pharmaceutics15082051
Chicago/Turabian Style
Siwecka, Natalia, Kamil Saramowicz, Grzegorz Galita, Wioletta Rozpędek-Kamińska, and Ireneusz Majsterek.
2023. "Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy" Pharmaceutics 15, no. 8: 2051.
https://doi.org/10.3390/pharmaceutics15082051
APA Style
Siwecka, N., Saramowicz, K., Galita, G., Rozpędek-Kamińska, W., & Majsterek, I.
(2023). Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy. Pharmaceutics, 15(8), 2051.
https://doi.org/10.3390/pharmaceutics15082051